Sulfuric acid sales are a pass-through causing sales to be lumpy, which is why ECVT reduced its sales outlook for 2022. However, adjusted EBITDA is now forecast towards the high end of the range
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.